Semiconductors
Compare Stocks
5 / 10Stock Comparison
ALAB vs MRVL vs AVGO vs CRUS vs MPWR
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
ALAB vs MRVL vs AVGO vs CRUS vs MPWR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $34.01B | $147.33B | $2.04T | $8.76B | $78.63B |
| Revenue (TTM) | $1.00B | $8.19B | $68.28B | $2.00B | $2.79B |
| Net Income (TTM) | $268M | $2.67B | $24.97B | $414M | $616M |
| Gross Margin | 76.0% | 51.0% | 67.1% | 52.8% | 55.2% |
| Operating Margin | 22.4% | 16.1% | 40.9% | 23.0% | 26.1% |
| Forward P/E | 67.6x | 44.3x | 38.0x | 18.9x | 67.2x |
| Total Debt | $35M | $4.47B | $65.14B | $134M | $24M |
| Cash & Equiv. | $168M | $2.64B | $16.18B | $801M | $1.10B |
ALAB vs MRVL vs AVGO vs CRUS vs MPWR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 24 | May 26 | Return |
|---|---|---|---|
| Astera Labs, Inc. C… (ALAB) | 100 | 269.3 | +169.3% |
| Marvell Technology,… (MRVL) | 100 | 240.0 | +140.0% |
| Broadcom Inc. (AVGO) | 100 | 324.4 | +224.4% |
| Cirrus Logic, Inc. (CRUS) | 100 | 185.5 | +85.5% |
| Monolithic Power Sy… (MPWR) | 100 | 236.3 | +136.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALAB vs MRVL vs AVGO vs CRUS vs MPWR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALAB is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 115.1%, EPS growth 290.6%, 3Y rev CAGR 120.2%
- 115.1% revenue growth vs CRUS's 5.3%
- 18.3% ROA vs MRVL's 12.6%, ROIC 12.3% vs 6.0%
MRVL ranks third and is worth considering specifically for momentum.
- +195.6% vs CRUS's +75.9%
AVGO carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 16 yrs, beta 1.96, yield 0.5%
- 30.2% 10Y total return vs MPWR's 25.3%
- PEG 0.76 vs MPWR's 2.28
- Beta 1.96, yield 0.5%, current ratio 1.71x
CRUS is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.09, Low D/E 6.3%, current ratio 7.37x
- Beta 1.09 vs ALAB's 3.03
Among these 5 stocks, MPWR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 115.1% revenue growth vs CRUS's 5.3% | |
| Value | Lower P/E (38.0x vs 67.2x), PEG 0.76 vs 2.28 | |
| Quality / Margins | 36.6% margin vs CRUS's 20.7% | |
| Stability / Safety | Beta 1.09 vs ALAB's 3.03 | |
| Dividends | 0.5% yield, 16-year raise streak, vs MPWR's 0.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +195.6% vs CRUS's +75.9% | |
| Efficiency (ROA) | 18.3% ROA vs MRVL's 12.6%, ROIC 12.3% vs 6.0% |
ALAB vs MRVL vs AVGO vs CRUS vs MPWR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ALAB vs MRVL vs AVGO vs CRUS vs MPWR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVGO leads in 2 of 6 categories
CRUS leads 1 • ALAB leads 0 • MRVL leads 0 • MPWR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — ALAB and AVGO each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVGO is the larger business by revenue, generating $68.3B annually — 68.2x ALAB's $1.0B. AVGO is the more profitable business, keeping 36.6% of every revenue dollar as net income compared to CRUS's 20.7%. On growth, ALAB holds the edge at +93.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.0B | $8.2B | $68.3B | $2.0B | $2.8B |
| EBITDAEarnings before interest/tax | $233M | $2.3B | $38.8B | $486M | $781M |
| Net IncomeAfter-tax profit | $268M | $2.7B | $25.0B | $414M | $616M |
| Free Cash FlowCash after capex | $343M | $1.4B | $28.9B | $488M | $664M |
| Gross MarginGross profit ÷ Revenue | +76.0% | +51.0% | +67.1% | +52.8% | +55.2% |
| Operating MarginEBIT ÷ Revenue | +22.4% | +16.1% | +40.9% | +23.0% | +26.1% |
| Net MarginNet income ÷ Revenue | +26.7% | +32.6% | +36.6% | +20.7% | +22.1% |
| FCF MarginFCF ÷ Revenue | +34.2% | +17.0% | +42.3% | +24.4% | +23.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +93.4% | +22.1% | +29.5% | +5.7% | +20.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +144.4% | +100.0% | +31.6% | +19.1% | -88.4% |
Valuation Metrics
CRUS leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 21.9x trailing earnings, CRUS trades at a 87% valuation discount to ALAB's 163.8x P/E. Adjusting for growth (PEG ratio), CRUS offers better value at 1.31x vs MPWR's 4.26x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $34.0B | $147.3B | $2.04T | $8.8B | $78.6B |
| Enterprise ValueMkt cap + debt − cash | $33.9B | $149.2B | $2.09T | $8.1B | $77.6B |
| Trailing P/EPrice ÷ TTM EPS | 163.76x | 55.42x | 90.15x | 21.90x | 125.56x |
| Forward P/EPrice ÷ next-FY EPS est. | 67.61x | 44.32x | 37.99x | 18.94x | 67.24x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.81x | 1.31x | 4.26x |
| EV / EBITDAEnterprise value multiple | 187.93x | 112.76x | 60.94x | 16.64x | 99.47x |
| Price / SalesMarket cap ÷ Revenue | 39.89x | 17.98x | 31.91x | 4.38x | 28.18x |
| Price / BookPrice ÷ Book value/share | 26.31x | 10.34x | 25.67x | 4.22x | 21.90x |
| Price / FCFMarket cap ÷ FCF | 120.69x | 105.51x | 75.75x | — | 118.03x |
Profitability & Efficiency
Evenly matched — CRUS and MPWR each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
AVGO delivers a 32.9% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $18 for MPWR. MPWR carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVGO's 0.80x. On the Piotroski fundamental quality scale (0–9), AVGO scores 8/9 vs ALAB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.3% | +19.4% | +32.9% | +20.2% | +17.9% |
| ROA (TTM)Return on assets | +18.3% | +12.6% | +14.9% | +17.1% | +15.2% |
| ROICReturn on invested capital | +12.3% | +6.0% | +14.9% | +22.9% | +22.2% |
| ROCEReturn on capital employed | +14.7% | +7.1% | +16.9% | +20.8% | +20.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 8 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.03x | 0.31x | 0.80x | 0.06x | 0.01x |
| Net DebtTotal debt minus cash | -$132M | $1.8B | $49.0B | -$667M | -$1.1B |
| Cash & Equiv.Liquid assets | $168M | $2.6B | $16.2B | $801M | $1.1B |
| Total DebtShort + long-term debt | $35M | $4.5B | $65.1B | $134M | $24M |
| Interest CoverageEBIT ÷ Interest expense | — | 15.17x | 9.24x | 703.54x | — |
Total Returns (Dividends Reinvested)
AVGO leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AVGO five years ago would be worth $100,886 today (with dividends reinvested), compared to $22,929 for CRUS. Over the past 12 months, MRVL leads with a +195.6% total return vs CRUS's +75.9%. The 3-year compound annual growth rate (CAGR) favors AVGO at 90.8% vs CRUS's 30.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +11.3% | +90.5% | +23.9% | +43.5% | +71.2% |
| 1-Year ReturnPast 12 months | +178.9% | +195.6% | +108.2% | +75.9% | +151.2% |
| 3-Year ReturnCumulative with dividends | +222.1% | +316.6% | +594.1% | +120.0% | +286.3% |
| 5-Year ReturnCumulative with dividends | +222.1% | +286.6% | +908.9% | +129.3% | +404.2% |
| 10-Year ReturnCumulative with dividends | +222.1% | +1686.0% | +3019.8% | +421.3% | +2534.9% |
| CAGR (3Y)Annualised 3-year return | +47.7% | +60.9% | +90.8% | +30.1% | +56.9% |
Risk & Volatility
Evenly matched — AVGO and CRUS each lead in 1 of 2 comparable metrics.
Risk & Volatility
CRUS is the less volatile stock with a 1.09 beta — it tends to amplify market swings less than ALAB's 3.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AVGO currently trades 98.2% from its 52-week high vs ALAB's 76.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.03x | 2.27x | 1.96x | 1.09x | 2.27x |
| 52-Week HighHighest price in past year | $262.90 | $175.79 | $437.68 | $179.00 | $1662.00 |
| 52-Week LowLowest price in past year | $69.26 | $56.69 | $203.69 | $92.02 | $630.00 |
| % of 52W HighCurrent price vs 52-week peak | +76.0% | +96.8% | +98.2% | +95.9% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 58.4 | 63.7 | 60.0 | 62.1 | 61.6 |
| Avg Volume (50D)Average daily shares traded | 5.1M | 24.9M | 23.1M | 602K | 578K |
Analyst Outlook
AVGO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ALAB as "Buy", MRVL as "Buy", AVGO as "Buy", CRUS as "Buy", MPWR as "Buy". Consensus price targets imply 15.3% upside for ALAB (target: $230) vs -21.8% for MRVL (target: $133). For income investors, AVGO offers the higher dividend yield at 0.53% vs MRVL's 0.14%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $230.27 | $133.10 | $443.72 | $169.00 | $1615.00 |
| # AnalystsCovering analysts | 16 | 72 | 58 | 22 | 25 |
| Dividend YieldAnnual dividend ÷ price | — | +0.1% | +0.5% | — | +0.4% |
| Dividend StreakConsecutive years of raises | — | 0 | 16 | 1 | 8 |
| Dividend / ShareAnnual DPS | — | $0.24 | $2.30 | — | $5.90 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% | +0.3% | 0.0% | +0.0% |
AVGO leads in 2 of 6 categories (Total Returns, Analyst Outlook). CRUS leads in 1 (Valuation Metrics). 3 tied.
ALAB vs MRVL vs AVGO vs CRUS vs MPWR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALAB or MRVL or AVGO or CRUS or MPWR a better buy right now?
For growth investors, Astera Labs, Inc.
Common Stock (ALAB) is the stronger pick with 115. 1% revenue growth year-over-year, versus 5. 3% for Cirrus Logic, Inc. (CRUS). Cirrus Logic, Inc. (CRUS) offers the better valuation at 21. 9x trailing P/E (18. 9x forward), making it the more compelling value choice. Analysts rate Astera Labs, Inc. Common Stock (ALAB) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALAB or MRVL or AVGO or CRUS or MPWR?
On trailing P/E, Cirrus Logic, Inc.
(CRUS) is the cheapest at 21. 9x versus Astera Labs, Inc. Common Stock at 163. 8x. On forward P/E, Cirrus Logic, Inc. is actually cheaper at 18. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Broadcom Inc. wins at 0. 76x versus Monolithic Power Systems, Inc. 's 2. 28x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ALAB or MRVL or AVGO or CRUS or MPWR?
Over the past 5 years, Broadcom Inc.
(AVGO) delivered a total return of +908. 9%, compared to +129. 3% for Cirrus Logic, Inc. (CRUS). Over 10 years, the gap is even starker: AVGO returned +30. 2% versus ALAB's +222. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALAB or MRVL or AVGO or CRUS or MPWR?
By beta (market sensitivity over 5 years), Cirrus Logic, Inc.
(CRUS) is the lower-risk stock at 1. 09β versus Astera Labs, Inc. Common Stock's 3. 03β — meaning ALAB is approximately 177% more volatile than CRUS relative to the S&P 500. On balance sheet safety, Monolithic Power Systems, Inc. (MPWR) carries a lower debt/equity ratio of 1% versus 80% for Broadcom Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALAB or MRVL or AVGO or CRUS or MPWR?
By revenue growth (latest reported year), Astera Labs, Inc.
Common Stock (ALAB) is pulling ahead at 115. 1% versus 5. 3% for Cirrus Logic, Inc. (CRUS). On earnings-per-share growth, the picture is similar: Marvell Technology, Inc. grew EPS 401. 0% year-over-year, compared to -65. 2% for Monolithic Power Systems, Inc.. Over a 3-year CAGR, ALAB leads at 120. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALAB or MRVL or AVGO or CRUS or MPWR?
Broadcom Inc.
(AVGO) is the more profitable company, earning 36. 2% net margin versus 20. 7% for Cirrus Logic, Inc. — meaning it keeps 36. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVGO leads at 39. 9% versus 16. 1% for MRVL. At the gross margin level — before operating expenses — ALAB leads at 75. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALAB or MRVL or AVGO or CRUS or MPWR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Broadcom Inc. (AVGO) is the more undervalued stock at a PEG of 0. 76x versus Monolithic Power Systems, Inc. 's 2. 28x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Cirrus Logic, Inc. (CRUS) trades at 18. 9x forward P/E versus 67. 6x for Astera Labs, Inc. Common Stock — 48. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALAB: 15. 3% to $230. 27.
08Which pays a better dividend — ALAB or MRVL or AVGO or CRUS or MPWR?
In this comparison, AVGO (0.
5% yield), MPWR (0. 4% yield), MRVL (0. 1% yield) pay a dividend. ALAB, CRUS do not pay a meaningful dividend and should not be held primarily for income.
09Is ALAB or MRVL or AVGO or CRUS or MPWR better for a retirement portfolio?
For long-horizon retirement investors, Cirrus Logic, Inc.
(CRUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 09), +421. 3% 10Y return). Monolithic Power Systems, Inc. (MPWR) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CRUS: +421. 3%, MPWR: +25. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALAB and MRVL and AVGO and CRUS and MPWR?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ALAB is a mid-cap high-growth stock; MRVL is a mid-cap high-growth stock; AVGO is a mega-cap high-growth stock; CRUS is a small-cap quality compounder stock; MPWR is a mid-cap high-growth stock. AVGO pays a dividend while ALAB, MRVL, CRUS, MPWR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.